The estimated Net Worth of Eric E Poma is at least 2.11 百万$ dollars as of 27 April 2022. Eric Poma owns over 34,156 units of Molecular Templates Inc stock worth over 380,333$ and over the last 7 years he sold MTEM stock worth over 0$. In addition, he makes 1,733,740$ as Chief Executive Officer、 Chief Scientific Officer、 Director at Molecular Templates Inc.
Sign up
Eric Poma MTEM stock SEC Form 4 insiders trading
Eric has made over 2 trades of the Molecular Templates Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently he exercised 34,156 units of MTEM stock worth 24,251$ on 27 April 2022.
The largest trade he's ever made was exercising 239,896 units of Molecular Templates Inc stock on 26 November 2018 worth over 127,145$. On average, Eric trades about 27,405 units every 125 days since 2017. As of 27 April 2022 he still owns at least 277,615 units of Molecular Templates Inc stock.
You can see the complete history of Eric Poma stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Eric Poma biography
Dr. Eric E. Poma Ph.D. serves as Chief Executive Officer, Chief Scientific Officer, Director of the Company. Dr. Poma is the Chief Executive Officer and Chief Scientific Officer of the Company and founded Private Molecular in February 2009, serving on its board of directors since its inception. From March 2005 until September 2008, Dr. Poma was Vice President of Business Development of Innovive Pharmaceuticals (acquired by Cytrx Corporation), a biotechnology company. From 2001 to 2005, he served as the Associate Vice President of Business Development at ImClone Systems, Inc. (now Eli Lilly and Company), a biotechnology company focused on antibody therapeutics. As the founder of Private Molecular and in his role as Chief Scientific Officer, he led the invention of technology underlying the Company’s platform technology and what constitutes the whole of the Company’s current lead and preclinical pipeline candidates. Dr. Poma received his Ph.D. in Microbiology and Immunology and B.A. in Biology from the University of North Carolina at Chapel Hill and his M.B.A. from New York University. Our Board has concluded that Dr. Poma should serve as a director of the Company based on Dr. Poma’s direct involvement in the creation of, and knowledge of, our technology platform and extensive experience in the industry, which provides invaluable insight to our Board on matters involving the Company and its future goals. Our Board has concluded that having the Chief Executive Officer as a director is an optimal way of ensuring the most efficient execution and development of the Company’s business goals and strategies.
What is the salary of Eric Poma?
As the Chief Executive Officer、 Chief Scientific Officer、 Director of Molecular Templates Inc, the total compensation of Eric Poma at Molecular Templates Inc is 1,733,740$. There are no executives at Molecular Templates Inc getting paid more.
How old is Eric Poma?
Eric Poma is 48, he's been the Chief Executive Officer、 Chief Scientific Officer、 Director of Molecular Templates Inc since 2017. There are 12 older and 7 younger executives at Molecular Templates Inc. The oldest executive at Molecular Templates Inc is David Hoffmann, 75, who is the Independent Director.
What's Eric Poma's mailing address?
Eric's mailing address filed with the SEC is C/O MOLECULAR TEMPLATES, INC., 9301 AMBERGLEN BLVD., SUITE 100, AUSTIN, TX, 78729.
Insiders trading at Molecular Templates Inc
Over the last 7 years, insiders at Molecular Templates Inc have traded over 22,993,582$ worth of Molecular Templates Inc stock and bought 14,744,530 units worth 82,519,716$ . The most active insiders traders include Target N Vbb Biotech Ag Bio...、David Hirsch、Capital Partners Iii, Llc L.... On average, Molecular Templates Inc executives and independent directors trade stock every 47 days with the average trade being worth of 532,718$. The most recent stock trade was executed by Target N Vbb Biotech Ag Bio... on 2 April 2024, trading 250,000 units of MTEM stock currently worth 587,500$.
What does Molecular Templates Inc do?
molecular templates (mtem) is a clinical-stage biopharmaceutical company targeting a variety of cancers through development of its innovative proprietary engineered toxin body (etb) platform. mtem’s first immunotoxin, mt-3724, is in clinical development for non-hodgkin’s lymphoma. pipeline products for additional oncology targets are being advanced toward clinical development. for more information, please visit mtem’s website at www.mtem.com.
What does Molecular Templates Inc's logo look like?
Complete history of Eric Poma stock trades at Molecular Templates Inc
Molecular Templates Inc executives and stock owners
Molecular Templates Inc executives and other stock owners filed with the SEC include:
-
Eric Poma,
Chief Executive Officer, Chief Scientific Officer, Director -
Roger Waltzman,
Chief Medical Officer -
Jason Kim,
President, Chief Operating Officer -
Adam Cutler,
Chief Financial Officer, Treasurer, Secretary -
Dr. Eric E. Poma,
CEO, Chief Scientific Officer & Director -
Dr. Roger J. Waltzman M.B.A., M.D.,
Chief Medical Officer -
Jason S Kim,
Pres & COO -
Dr. Roger J. Waltzman,
Chief Medical Officer -
Corazon Sanders,
Independent Director -
Harold Selick,
Chairman of the Board -
Kevin Lalande,
Independent Director -
David Hirsch,
Independent Director -
David Hoffmann,
Independent Director -
Scott Morenstein,
Independent Director -
Jonathan Lanfear,
Independent Director -
Michael Dowd,
Sr. VP of Project & Alliance Management -
Megan C. Filoon,
Gen. Counsel & Sec. -
Dr. Nenad Sarapa M.D., M.S.,
Sr. VP of Clinical Devel. -
Dr. Jen-Sing Liu Ph.D.,
Exec. VP of Manufacturing -
Dr. Erin Willert Ph.D.,
Exec. VP of R&D -
Dr. Jack Higgins Ph.D.,
Exec. VP of Operations & Head of Manufacturing -
Kurt Elster,
Exec. VP of Corp. Devel. -
Sean McLennan,
Sr. VP of Fin., Controller, Interim Principal Accounting Officer, Interim CFO & Treasurer -
Associates, L.L.C.Morenstei...,
-
Target N Vbb Biotech Ag Bio...,
-
Dave Hoffmann,
Director -
Capital Partners Iii, Llc L...,
-
Scott Dcdk Associates, L.L....,
-
Management Services, Llc Cu...,
-
Sean Mc Lennan,
See remarks -
Management Services, Llc Cu...,
-
Gabriela Gruia,
Director -
Maurizio Voi,
Chief Medical Officer